EQRx
Cambridge
About EQRx
EQRx operates as a biotechnology company, focused on re-engineering the process from drug discovery to patient delivery with the goal of offering a market-based solution for the rising cost of medicines. By bringing together stakeholders from across the healthcare system and utilizing the latest advances in science and technology, the company seeks to discover, develop and deliver high-quality, patent-protected medicines more efficiently and cost-effectively than ever before. The company was founded in 2019 and is based in Cambridge, Massachusetts, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 251 – 500
- Total funding: $1.9B
- Funding stage: M&A
- Last round: Post-IPO Equity (Dec 2021)
- Ticker: nasdaq:EQRX
- Website: eqrx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/eqrx-96491 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.